PUBLISHER: TechNavio | PRODUCT CODE: 2144770
PUBLISHER: TechNavio | PRODUCT CODE: 2144770
Global Human Organoids Market 2026-2030
The global human organoids market is forecasted to grow by USD 1551.3 mn during 2025-2030, accelerating at a CAGR of 16.7% during the forecast period. The report on the global human organoids market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing adoption of organoid-based models in drug discovery programs, advancing precision medicine applications utilizing patient-derived organoids, growing biopharmaceutical research investment in advanced disease modeling.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 15.9% |
| CAGR | 16.7% |
| Incremental Value | $1551.3 mn |
Technavio's global human organoids market is segmented as below:
By End-User
- Pharma and biotech companies
- Contract research organizations
- Academic and research institutes
- Others
By Source
- Adult stem cells
- iPSCs
- ESCs
- Others
By Product
- Organoid models
- Media and supplements
- Reagents
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the expanding integration of ai-enabled analytics in organoid research workflows as one of the prime reasons driving the global human organoids market growth during the next few years. Also, evolving multi-organoid platforms for cross-tissue biological investigations and growing collaboration between academic institutions and biotechnology companies for organoid commercialization will lead to sizable demand in the market.
The report on the global human organoids market covers the following areas:
- Global human organoids market sizing
- Global human organoids market forecast
- Global human organoids market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global human organoids market vendors that include 3DNamics Inc., ACROBiosystems Co. Ltd., BICO Group AB, BioIVT LLC, CN Bio Innovations Ltd., Corning Inc., Cypre Inc., Emulate Inc., InSphero AG, Kirkstall Ltd., MIMETAS BV, Molecular Device LLC, Neuromics Inc., Pandorum Technologies Pvt. Ltd., Sigma Aldrich Chemicals Ltd., Sino Biological Inc., STEMCELL Technologies Inc., The Organoid Co, Thermo Fisher Scientific Inc., ZenBio Inc.. Also, the global human organoids market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Source
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Human Organoids Market 2020 - 2024
- Historic Market Size - Data Table on Global Human Organoids Market 2020 - 2024 ($ million)
- 5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.3 Source segment analysis 2020 - 2024
- Historic Market Size - Source Segment 2020 - 2024 ($ million)
- 5.4 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global human organoids market
- 6.2 Impact of geopolitical conflicts on global human organoids market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by End-user
- 8.1 Market segments
- 8.2 Comparison by End-user
- 8.3 Pharma and biotech companies - Market size and forecast 2025-2030
- 8.4 Contract research organizations - Market size and forecast 2025-2030
- 8.5 Academic and research institutes - Market size and forecast 2025-2030
- 8.6 Others - Market size and forecast 2025-2030
- 8.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
9 Market Segmentation by Source
- 9.1 Market segments
- 9.2 Comparison by Source
- 9.3 Adult stem cells - Market size and forecast 2025-2030
- 9.4 iPSCs - Market size and forecast 2025-2030
- 9.5 ESCs - Market size and forecast 2025-2030
- 9.6 Others - Market size and forecast 2025-2030
- 9.7 Market opportunity by Source
- Market opportunity by Source ($ million)
10 Market Segmentation by Product
- 10.1 Market segments
- 10.2 Comparison by Product
- 10.3 Organoid models - Market size and forecast 2025-2030
- 10.4 Media and supplements - Market size and forecast 2025-2030
- 10.5 Reagents - Market size and forecast 2025-2030
- 10.6 Market opportunity by Product
- Market opportunity by Product ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 South Africa - Market size and forecast 2025-2030
- 12.6.6 Argentina - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing adoption of organoid-based models in drug discovery programs
- Advancing precision medicine applications utilizing patient-derived organoids
- Growing biopharmaceutical research investment in advanced disease modeling
- 13.2 Market challenges
- High cost burden associated with organoid development and maintenance
- Limited standardization across organoid production workflows
- Complex ethical and regulatory requirements for human tissue utilization
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Expanding integration of AI-enabled analytics in organoid research workflows
- Evolving multi-organoid platforms for cross-tissue biological investigations
- Growing collaboration between academic institutions and biotechnology companies for organoid commercialization
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 ACROBiosystems Co. Ltd.
- ACROBiosystems Co. Ltd. - Overview
- ACROBiosystems Co. Ltd. - Product / Service
- ACROBiosystems Co. Ltd. - Key offerings
- SWOT
- 15.5 BICO Group AB
- BICO Group AB - Overview
- BICO Group AB - Business segments
- BICO Group AB - Key offerings
- BICO Group AB - Segment focus
- SWOT
- 15.6 BioIVT LLC
- BioIVT LLC - Overview
- BioIVT LLC - Product / Service
- BioIVT LLC - Key offerings
- SWOT
- 15.7 Corning Inc.
- Corning Inc. - Overview
- Corning Inc. - Business segments
- Corning Inc. - Key offerings
- Corning Inc. - Segment focus
- SWOT
- 15.8 Cypre Inc.
- Cypre Inc. - Overview
- Cypre Inc. - Product / Service
- Cypre Inc. - Key offerings
- SWOT
- 15.9 Emulate Inc.
- Emulate Inc. - Overview
- Emulate Inc. - Product / Service
- Emulate Inc. - Key offerings
- SWOT
- 15.10 InSphero AG
- InSphero AG - Overview
- InSphero AG - Product / Service
- InSphero AG - Key offerings
- SWOT
- 15.11 MIMETAS BV
- MIMETAS BV - Overview
- MIMETAS BV - Product / Service
- MIMETAS BV - Key offerings
- SWOT
- 15.12 Molecular Device LLC
- Molecular Device LLC - Overview
- Molecular Device LLC - Product / Service
- Molecular Device LLC - Key offerings
- SWOT
- 15.13 Pandorum Technologies Pvt. Ltd.
- Pandorum Technologies Pvt. Ltd. - Overview
- Pandorum Technologies Pvt. Ltd. - Product / Service
- Pandorum Technologies Pvt. Ltd. - Key offerings
- SWOT
- 15.14 Sigma Aldrich Chemicals Ltd.
- Sigma Aldrich Chemicals Ltd. - Overview
- Sigma Aldrich Chemicals Ltd. - Product / Service
- Sigma Aldrich Chemicals Ltd. - Key offerings
- SWOT
- 15.15 Sino Biological Inc.
- Sino Biological Inc. - Overview
- Sino Biological Inc. - Product / Service
- Sino Biological Inc. - Key offerings
- SWOT
- 15.16 STEMCELL Technologies Inc.
- STEMCELL Technologies Inc. - Overview
- STEMCELL Technologies Inc. - Product / Service
- STEMCELL Technologies Inc. - Key offerings
- SWOT
- 15.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.18 ZenBio Inc.
- ZenBio Inc. - Overview
- ZenBio Inc. - Product / Service
- ZenBio Inc. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
